Gastroenterology — MCQs

Gastroenterology Indian Medical PG Practice Questions and MCQs

Question 1161: A 45-year-old female presents with a long-standing history of heartburn and regurgitation. Endoscopy reveals Barrett's esophagus. What is the primary concern for this patient?

A. Gastric ulcer
B. Esophageal cancer (Correct Answer)
C. Peptic stricture
D. Achalasia

Explanation: ***Esophageal cancer*** - Barrett's esophagus is a precancerous condition that significantly increases the risk of **adenocarcinoma** of the esophagus [3]. - Regular surveillance is necessary due to potential **malignant transformation** in patients with Barrett's esophagus [3]. *Achalasia* - This condition presents with **dysphagia** for solids and liquids and does not show a direct link to Barrett's esophagus. - It primarily affects the **lower esophageal sphincter**, leading to **esophageal dilation** rather than a concern for cancer [1]. *Peptic stricture* - While this may occur due to chronic gastroesophageal reflux, it is not as significant a concern as **esophageal cancer** in patients with Barrett's esophagus [2]. - Peptic strictures are typically **benign** and can be treated with dilation [1]. *Gastric ulcer* - Gastric ulcers are unrelated to Barrett's esophagus and present differently, mainly with **epigastric pain**. - They do not stem from **chronic reflux** and thus are not a primary concern in this patient.

Question 1162: A 30-year-old female presents with progressive difficulty swallowing and a sensation of a lump in her throat. A barium swallow shows a filling defect in the esophagus. What is the most likely diagnosis?

A. Esophageal stricture
B. Achalasia
C. Esophageal carcinoma (Correct Answer)
D. Esophageal web

Explanation: ***Esophageal carcinoma*** - Progressive **dysphagia** (difficulty swallowing) and a sensation of a **lump in the throat** in a 30-year-old, especially with a **filling defect on barium swallow**, raise strong suspicion for esophageal carcinoma, although less common in this age group, it must be ruled out with an endoscopy and biopsy [1]. - While other conditions can cause dysphagia, the "filling defect" points towards a **mass lesion** rather than functional or circumferential narrowing. *Esophageal stricture* - An **esophageal stricture** typically presents with progressive dysphagia, but it is a **narrowing** of the esophagus, not usually a distinct filling defect on barium swallow. - Strictures are often caused by **GERD** or caustic injury and would show as a smooth, localized narrowing. *Achalasia* - **Achalasia** is a motility disorder characterized by incomplete relaxation of the **lower esophageal sphincter** and aperistalsis of the esophageal body, leading to dysphagia for both solids and liquids [2]. - Barium swallow typically shows a **'bird's beak' appearance** due to distal esophageal narrowing but no filling defect [2]. *Esophageal web* - An **esophageal web** is a thin, usually anterior, abnormal growth of mucosa in the esophagus that causes intermittent dysphagia, particularly with solids. - It would appear as a **thin, shelf-like constriction** on a barium swallow, not a filling defect.

Question 1163: Which of the following laboratory values is NOT included in the MELD score?

A. INR (International Normalized Ratio)
B. Serum bilirubin
C. Serum creatinine
D. Alkaline phosphatase (Correct Answer)

Explanation: ***Alkaline phosphatase*** - **Alkaline phosphatase** is a liver enzyme that can be elevated in various liver conditions, particularly those involving **biliary obstruction** [1], but it is not a component of the MELD score calculation. - The MELD score focuses on markers of **liver synthetic function** and **renal impairment** [2], not enzymes indicative of cholestasis or hepatocellular damage alone. *Serum bilirubin* - **Serum bilirubin** is a crucial component of the MELD score, reflecting the liver's ability to **process and excrete bilirubin**, a byproduct of red blood cell breakdown [1]. - Elevated bilirubin levels indicate **impaired liver function**, often seen in advanced liver disease. *Serum creatinine* - **Serum creatinine** is included in the MELD score to account for **renal dysfunction** [2], which is a common and serious complication in patients with end-stage liver disease. - **Kidney impairment** significantly impacts the prognosis of patients awaiting liver transplantation. *INR (International Normalized Ratio)* - The **INR** measures the **extrinsic pathway of coagulation** and reflects the liver's capacity to synthesize **clotting factors** (II, VII, IX, X). [2] - An elevated INR indicates **impaired liver synthetic function**, making it a key prognostic indicator in the MELD score.

Question 1164: Which test is most useful in differentiating between Irritable Bowel Syndrome (IBS) and organic gastrointestinal diseases?

A. Stool calprotectin
B. Colonoscopy (Correct Answer)
C. Abdominal ultrasound
D. Fecal occult blood test

Explanation: ***Colonoscopy*** - A definitive **colonoscopy** allows for direct visualization of the colonic mucosa, enabling the identification of **inflammation**, **ulcers**, or **polyps** characteristic of organic GI diseases [1]. - While IBS is a **functional disorder** with no visible abnormalities on colonoscopy, this procedure can rule out **inflammatory bowel disease (IBD)**, **colorectal cancer**, or **microscopic colitis** [1]. *Stool calprotectin* - **Stool calprotectin** is a marker of intestinal inflammation and is typically elevated in **inflammatory bowel disease (IBD)** but normal in IBS. - Although useful for screening out IBD, it does not provide definitive diagnosis or rule out other organic causes like **microscopic colitis** or **colorectal cancer**. *Abdominal ultrasound* - An **abdominal ultrasound** is primarily used to evaluate intra-abdominal organs like the liver, gallbladder, pancreas, and kidneys, but it has limited utility in visualizing the bowel wall or detecting microscopic inflammation. - It is not sensitive or specific enough to differentiate between IBS and many **organic gastrointestinal diseases** that affect the colon directly. *Fecal occult blood test* - A **fecal occult blood test** detects hidden blood in the stool, which can indicate **gastrointestinal bleeding** from conditions like **colorectal cancer**, **ulcers**, or **inflammatory bowel disease** [2]. - While positive results suggest a need for further investigation, a negative result does not rule out all organic diseases (e.g., microscopic colitis, celiac disease, or non-bleeding polyps) and is therefore not definitive for differentiating from IBS [2].

Question 1165: Which of the following causes of acute pancreatitis can cause recurrent bouts without any obvious pathology?

A. Sphincter of Oddi dysfunction
B. Pancreas divisum
C. Hypertriglyceridemia
D. All of the options (Correct Answer)

Explanation: ***All of the options*** - **Sphincter of Oddi dysfunction**, **Pancreas divisum**, and **Hypertriglyceridemia** are all recognized causes of recurrent acute pancreatitis without always presenting obvious structural pathology on initial imaging like ultrasound or CT [1]. - These conditions can lead to repeated episodes of pancreatitis due to intermittent obstruction, abnormal pancreatic duct anatomy, or direct toxic effects, respectively, which may be difficult to diagnose without specific investigations [1]. *Sphincter of Oddi dysfunction* - This condition involves **spasms or stenosis of the sphincter of Oddi**, leading to impaired outflow of pancreatic and biliary secretions [1]. - The obstruction can be intermittent, causing recurrent attacks of pancreatitis without a visible stone or mass on routine imaging. *Pancreas divisum* - It is a **congenital anomaly** where the dorsal and ventral pancreatic ducts fail to fuse, leading to drainage of the dominant dorsal pancreas through a smaller accessory papilla. - This narrow opening can lead to **relative obstruction** and recurrent episodes of acute pancreatitis, especially when the main drainage is through the minor papilla. *Hypertriglyceridemia* - Significantly elevated levels of **triglycerides (typically >1000 mg/dL)** can directly cause damage to pancreatic acinar cells. - This condition can precipitate recurrent bouts of acute pancreatitis, and the underlying hypertriglyceridemia may not always be immediately recognized as the cause without specific lipid panel testing.

Question 1166: Which of the following statements about medical management of uncomplicated GERD is true?

A. Household measures such as tilting the bed can be effective.
B. PPIs are the most effective drug treatment for GERD. (Correct Answer)
C. An adequate dose of PPI for 8 weeks is the recommended treatment.
D. Long-term PPI therapy is associated with an increased risk of gastric malignancy.

Explanation: PPIs are the most effective drug treatment for GERD. [1] - Proton pump inhibitors (PPIs) are considered the most potent and effective medications for suppressing gastric acid secretion, which is the primary mechanism for treating GERD symptoms and healing esophagitis. - They work by irreversibly inhibiting the H+/K+-ATPase pump in gastric parietal cells, leading to a profound reduction in stomach acid. *Household measures such as tilting the bed can be effective.* - While lifestyle modifications like elevating the head of the bed, avoiding late meals, and dietary changes are often recommended, they are generally adjunctive measures and not the primary or most effective drug treatment for GERD symptoms. - These measures can help reduce reflux episodes but do not address the underlying acid secretion as effectively as medications. *An adequate dose of PPI for 8 weeks is the recommended treatment.* - An adequate dose of PPI for 8 weeks is indeed a common initial treatment course for GERD with esophagitis or severe symptoms but this statement refers to a specific treatment duration, not the general effectiveness of PPIs as a drug class. [1] - The most effective drug treatment refers to the class of medication that works best, which are PPIs. *Long-term PPI therapy is associated with an increased risk of gastric malignancy.* - While there are ongoing debates and studies regarding the long-term effects of PPIs, current evidence generally does not strongly support a direct causal link between long-term PPI therapy and an increased risk of gastric malignancy in the absence of Helicobacter pylori infection. [1] - Concerns about long-term PPI use often center around conditions like C. difficile infection, osteoporosis, and kidney disease, rather than gastric malignancy. [1]

Question 1167: How long after an attack of acute pancreatitis does a pancreatic pseudocyst typically develop?

A. Less than 1 week
B. Less than 2 weeks
C. 3 or more weeks
D. 4 or more weeks (Correct Answer)

Explanation: ***4 or more weeks*** - A **pancreatic pseudocyst** is a collection of pancreatic fluid that becomes encapsulated by a non-epithelialized fibrous wall. [1] - This encapsulation process typically takes **at least 4 weeks** to form after the initial acute pancreatitis attack. *Less than 1 week* - Within the first week of acute pancreatitis, the fluid collections are usually ill-defined, **peripancreatic fluid collections** without a well-formed wall. - These early collections are typically referred to as **acute peripancreatic fluid collections** (APFCs) or acute necrotic collections (ANCs) and do not meet the criteria for a pseudocyst. *Less than 2 weeks* - Fluid collections appearing within the first two weeks are still generally **unwalled** and do not have the characteristic fibrous capsule of a pseudocyst. [1] - They are considered acute fluid collections that may resolve spontaneously or evolve. *3 or more weeks* - While some organization might begin by 3 weeks, a **completely matured fibrous wall**, which defines a true pseudocyst, is generally not fully developed until **4 weeks or later**. - Collections at 3 weeks might still be evolving and may not yet be considered a stable pseudocyst.

Question 1168: Which of the following is MOST characteristic of gastric ulcers compared to duodenal ulcers?

A. Pain is more common during the day than at night.
B. Pain is relieved with ingestion of food
C. Hematemesis is more common than melena in gastric ulcers (Correct Answer)
D. Usually occurs in older adults.

Explanation: No relevant references with a score >= 7 were provided to support the clinical characteristics of gastric versus duodenal ulcers in the explanation. Hematemesis is more common than melena in gastric ulcers; gastric ulcers are located in the stomach, so if they bleed, the blood is more likely to be vomited before it has been digested enough to turn black (melena). The closer the bleeding source is to the mouth in the GI tract, the more likely freshly passed blood will be bright red (hematemesis). Pain is more common during the day than at night. While gastric ulcer pain can occur at any time, it is not specifically more common during the day compared to at night as a characteristic differentiator from duodenal ulcers. Duodenal ulcer pain is often described as nocturnal or occurring several hours after a meal, but this option does not isolate a unique feature of gastric ulcers. Usually occurs in older adults. While the incidence of peptic ulcer disease can increase with age, stating that gastric ulcers usually occur in older adults is not a characteristic distinguishing them from duodenal ulcers, as both can affect various age groups, and duodenal ulcers are often seen in younger to middle-aged adults. This statement is too general and does not provide a specific differentiating feature. Pain is relieved with ingestion of food. This description is more characteristic of duodenal ulcers, where food can transiently buffer stomach acid, alleviating the pain. In contrast, gastric ulcer pain is often worsened by food intake, as eating stimulates acid secretion and gastric motility.

Question 1169: Which of the following is a common prognostic factor for Acute Pancreatitis?

A. Serum Glucose
B. Serum AST
C. Serum Amylase
D. Serum Calcium (Correct Answer)

Explanation: ### Serum Calcium - **Hypocalcemia** is a common **prognostic indicator** in severe acute pancreatitis, often due to saponification of fat by pancreatic lipases, leading to calcium precipitation [1]. - A persistent decrease in serum calcium levels can correlate with a **worse prognosis** and increased risk of complications [1]. *Serum Amylase* - While **elevated serum amylase** is diagnostic of acute pancreatitis, its absolute level **does not correlate with disease severity** or prognosis. - Amylase levels can return to normal even while the patient is still very ill with severe pancreatitis. *Serum Glucose* - **Hyperglycemia** can occur in acute pancreatitis due to impaired insulin secretion or increased counter-regulatory hormones, and may be included in some severity scoring systems [1]. - However, it is generally considered **less sensitive or specific** as a standalone prognostic factor compared to other markers like calcium. *Serum AST* - **Elevated AST** (and ALT) typically indicates a **biliary etiology** for acute pancreatitis, such as gallstones. - While it helps determine the cause, **AST levels themselves are not a primary prognostic factor** for the overall severity or outcome of the pancreatitis.

Question 1170: Which of the following is the most sensitive and specific test for acute pancreatitis?

A. S.amylase
B. S.Alanine transaminase
C. S.lipase (Correct Answer)
D. C-reactive protein

Explanation: ***S.lipase*** - **Serum lipase** is considered the most sensitive and specific marker for **acute pancreatitis** because it remains elevated longer than amylase and is less commonly elevated in non-pancreatic conditions. - A level of **serum lipase** that is three times the upper limit of normal is highly indicative of **acute pancreatitis**. *S.amylase* - **Serum amylase** is often elevated in **acute pancreatitis**, but it is less specific than lipase, as it can also be elevated in other conditions like **salivary gland disease**, **bowel ischemia**, or **renal failure** [1]. - **Amylase** levels typically normalize within 3-5 days, whereas lipase levels can remain elevated for 8-14 days. *S.Alanine transaminase* - **Serum alanine transaminase (ALT)** is primarily a marker of **hepatocellular injury** and is not directly used for diagnosing **acute pancreatitis**. - While elevated **ALT** can sometimes suggest **gallstone pancreatitis** if significantly high (e.g., >150 U/L), it's not a diagnostic test for the pancreatitis itself. *C-reactive protein* - **C-reactive protein (CRP)** is an **acute-phase reactant** that indicates inflammation and tissue damage, and its levels rise in pancreatitis. - However, **CRP** is a non-specific marker of inflammation and is more useful for assessing the **severity** and **prognosis** of pancreatitis rather than for initial diagnosis [1].

Practice by Chapter

Esophageal Disorders

Practice Questions

Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Irritable Bowel Syndrome

Practice Questions

Malabsorption Syndromes

Practice Questions

Pancreatitis (Acute and Chronic)

Practice Questions

Gastrointestinal Bleeding

Practice Questions

Liver Diseases and Cirrhosis

Practice Questions

Viral Hepatitis

Practice Questions

Biliary Tract Disorders

Practice Questions

Gastrointestinal Motility Disorders

Practice Questions

Gastrointestinal Malignancies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free